Healthcare in Europe
57 views | +0 today
Follow
Healthcare in Europe
Pricing and Market Access hot topics in Europe
Curated by Alice BLEZAT
Your new post is loading...
Your new post is loading...
Scooped by Alice BLEZAT
Scoop.it!

Pricing-Cellular-Therapeutics_June2013-F.pdf

Alice BLEZAT's insight:

Article de Rebecca Walker sur les nouvelles considerations en termes de pricing pour les medicaments de therapie innovante (ATMP) en Europe

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

GlaxoSmithKline boss says new drugs can be cheaper

GlaxoSmithKline boss says new drugs can be cheaper | Healthcare in Europe | Scoop.it
LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive...
more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Turkey: A Promise Restored? - Pharmaceutical Executive

Turkey: A Promise Restored? - Pharmaceutical Executive | Healthcare in Europe | Scoop.it
After a decade of strife, the dialogue between industry and government appears to have entered a positive new phase. Julian Upton reports.
more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

L'OMS reconnaît le risque des perturbateurs endocriniens pour la ... - Les Échos

L'OMS reconnaît le risque des perturbateurs endocriniens pour la ... - Les Échos | Healthcare in Europe | Scoop.it
Les Échos
L'OMS reconnaît le risque des perturbateurs endocriniens pour la ...
more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Industry and EU clash over medical devices regulation

* Europe revisits rules after breast, hip implant scandals* Manufacturers fear new regulations will delay approvals* Debate centres on overhauling decentralised EU systemBy Ben HirschlerLONDON, Feb (@coreformulas Industry and EU clash over medical...
more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

expert reaction to story on QALY system | Science Media Centre

expert reaction to story on QALY system | Science Media Centre | Healthcare in Europe | Scoop.it
Alice BLEZAT's insight:

Reaction d'experts face a la critique europeenne des QALYs

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Estonia: The Pharmaceutical market in Q4 2012 - europe-health-care.eu

Estonia: The Pharmaceutical market in Q4 2012 - europe-health-care.eu | Healthcare in Europe | Scoop.it
Estonia: The Pharmaceutical market in Q4 2012: According to newest figures released by the Estonian Agency for M... http://t.co/Uq8XxT9n
Alice BLEZAT's insight:

Interested in what is going on in healthcare in Estonia?

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

European Medicines Agency - News and Events - Committee for Orphan Medicinal Products – strengthened interactions with patients and international partners

Alice BLEZAT's insight:

The Committee for Orphan Medicinal Products - EMA - to strenghten partnership with international HTA bodies and patients

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

PRICING CELLULAR THERAPEUTIC Considerations for Advanced Therapy Medicinal Products in the EU

PRICING CELLULAR THERAPEUTIC Considerations for Advanced Therapy Medicinal Products in the EU | Healthcare in Europe | Scoop.it
PriceSpective provides pharmaceutical pricing and reimbursement thought leadership, drug pricing research, price and market access trends, articles & presentations
Alice BLEZAT's insight:

Article de Rebecca Walker sur les nouvelles considerations en termes de pricing pour les medicaments de therapie innovante (ATMP) en Europe

http://pricespective.com/thought-leadership/

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Allergan adds MAP to migraine plans - FT.com

Allergan adds MAP to migraine plans - FT.com | Healthcare in Europe | Scoop.it
Allergan, the US maker of Botox, said late on Tuesday that it has acquired MAP Pharmaceuticals in a $958m deal that will expand its offering of migraine headache treatments.
more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Europe: Is National Drug Pricing Freedom Nearing its Expiry Date?

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Lansley confirms NICE will no longer take funding decisions

Lansley confirms NICE will no longer take funding decisions | Healthcare in Europe | Scoop.it
The National Institute for Health and Clinical Excellence will no longer directly decide whether the NHS funds a drug under the proposed new pricing system, health secretary Andrew Lansley has confirmed.
Alice BLEZAT's insight:

Beaucoup de questions en France et en Europe autour de l'utilisation des QALYs par le NICE. Des changemens a venir concernant les 'funding decisions' mais quel sera donc l'avenir du QALY?

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

European Medicines Agency - News and Events - Pharmacovigilance Risk Assessment Committee (PRAC) invites stakeholders’ feedback in review of Diane 35 and its generics

European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.
Alice BLEZAT's insight:

L'EMA invite les professionnels de sante et les associations de patients a donner leur commentaires et donnees concernant la re-evaluation de Diane35 et ses generiques

more...
No comment yet.
Scooped by Alice BLEZAT
Scoop.it!

Novo to sell Tresiba in Europe at 60-70 percent premium over Lantus

Novo to sell Tresiba in Europe at 60-70 percent premium over Lantus | Healthcare in Europe | Scoop.it
COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, will sell its long-acting insulin Tresiba in Europe at a 60-70 percent premium over rival product Lantus from France's Sanofi.
Alice BLEZAT's insight:
Tresiba (Novo Nordisk) would obtain a 60-70% premium to Lantus price although it was rejected by FDA few days ago. To be followed.
more...
No comment yet.